JPH0430924B2 - - Google Patents

Info

Publication number
JPH0430924B2
JPH0430924B2 JP25128484A JP25128484A JPH0430924B2 JP H0430924 B2 JPH0430924 B2 JP H0430924B2 JP 25128484 A JP25128484 A JP 25128484A JP 25128484 A JP25128484 A JP 25128484A JP H0430924 B2 JPH0430924 B2 JP H0430924B2
Authority
JP
Japan
Prior art keywords
substance
methyl
weight
solution
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP25128484A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61129129A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP25128484A priority Critical patent/JPS61129129A/ja
Publication of JPS61129129A publication Critical patent/JPS61129129A/ja
Publication of JPH0430924B2 publication Critical patent/JPH0430924B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP25128484A 1984-11-28 1984-11-28 抗腫瘍剤 Granted JPS61129129A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP25128484A JPS61129129A (ja) 1984-11-28 1984-11-28 抗腫瘍剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25128484A JPS61129129A (ja) 1984-11-28 1984-11-28 抗腫瘍剤

Publications (2)

Publication Number Publication Date
JPS61129129A JPS61129129A (ja) 1986-06-17
JPH0430924B2 true JPH0430924B2 (enExample) 1992-05-25

Family

ID=17220510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP25128484A Granted JPS61129129A (ja) 1984-11-28 1984-11-28 抗腫瘍剤

Country Status (1)

Country Link
JP (1) JPS61129129A (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW312694B (enExample) * 1994-09-26 1997-08-11 Daiichi Seiyaku Co
US6169086B1 (en) 1997-01-27 2001-01-02 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
CA2278677A1 (en) * 1997-01-27 1998-07-30 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
AU2004218260A1 (en) * 2003-01-28 2004-09-16 Aventis Pharma S.A. N-aryl heteroaromatic products, compositions containing same and use thereof
FR2850379B1 (fr) * 2003-01-28 2006-11-17 Aventis Pharma Sa Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
JP5756457B2 (ja) * 2009-04-06 2015-07-29 アジオス ファーマシューティカルズ， インコーポレイテッド ピルビン酸キナーゼｍ２調節剤、治療組成物および関連する使用方法
DK2448581T3 (en) 2009-06-29 2017-03-13 Agios Pharmaceuticals Inc Therapeutic compositions and methods for their applications
PE20120693A1 (es) 2009-06-29 2012-07-04 Agios Pharmaceuticals Inc Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2)
US9221792B2 (en) 2010-12-17 2015-12-29 Agios Pharmaceuticals, Inc N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators
WO2012088314A1 (en) 2010-12-21 2012-06-28 Agios Pharmaceuticals, Inc. Bicyclic pkm2 activators
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
PT3406251T (pt) 2011-05-03 2024-01-24 Agios Pharmaceuticals Inc Ativadores da piruvato-cinase para utilização em terapia
WO2012151440A1 (en) 2011-05-03 2012-11-08 Agios Pharmaceuticals, Inc. Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
WO2014139144A1 (en) 2013-03-15 2014-09-18 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
MX384883B (es) 2015-06-11 2025-03-14 Agios Pharmaceuticals Inc Métodos para usar activadores de piruvato cinasa.

Also Published As

Publication number Publication date
JPS61129129A (ja) 1986-06-17

Similar Documents

Publication Publication Date Title
JPS61129129A (ja) 抗腫瘍剤
JP2826379B2 (ja) チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤
KR100310121B1 (ko) 티아조푸린및리바비린을사용하는종양질환의치료방법
JPH07277964A (ja) 抗腫瘍剤
JPH0559892B2 (enExample)
HUP0203790A2 (hu) (6-Metoxi-2-naftil)-ecetsav prodrugokat tartalmazó gyógyszerkészítmények alkalmazása gyulladás kezelésére
JPH0548207B2 (enExample)
EP1203585B1 (en) Anti-ischemic agent
JPH0528690B2 (enExample)
EP0005074A1 (en) A material and composition for reducing blood pressure
JPH0324446B2 (enExample)
US20040142882A1 (en) Use of glycyrrhizin and its derivatives as RANTES inducers
JPH03502802A (ja) 抗嘔吐性エルゴリン誘導体
JPS61129121A (ja) 抗腫瘍剤
JPH0425933B2 (enExample)
JPH0442368B2 (enExample)
JPS61129128A (ja) 抗腫瘍剤
JPH0120128B2 (enExample)
JPH0329766B2 (enExample)
JPH0344049B2 (enExample)
JPH0649648B2 (ja) 酢酸誘導体を含有する抗腫瘍剤
JP2843944B2 (ja) 利胆剤
JPH072634B2 (ja) 酢酸誘導体を含有する抗腫瘍剤
JPH0528687B2 (enExample)
JPH072633B2 (ja) 酢酸誘導体を含有する抗腫瘍剤